Physical Functioning Throughout Lung Cancer Treatment
Launched by HASSELT UNIVERSITY · Jul 8, 2015
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Physical Functioning Throughout Lung Cancer Treatment," is exploring how different treatments for lung cancer affect patients' physical abilities, symptoms, and overall quality of life. The study aims to understand why some patients may feel weaker or less active during their treatment and how this can impact their daily lives. Researchers are looking for patients who are currently undergoing various treatments, including surgery, chemotherapy, immunotherapy, or radiation.
To participate, individuals must be receiving these treatments and have a good performance status, meaning they can carry out daily activities with minimal assistance. Unfortunately, those with certain other health conditions or previous lung cancer history may not qualify. If you decide to join this trial, you can expect to share information about your health and participate in assessments to help researchers gain insights into the effects of lung cancer treatment on physical functioning. This study is currently recruiting participants of all genders, and it could provide valuable information to improve the care and support for lung cancer patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • undergoing treatment (surgery, chemotherapy, immunotherapy, radiotherapy, and combination of the previous ones)
- • WHO performance status of maximal 2
- Exclusion Criteria:
- • presence of other neoplasms in the last 2 years
- • bone metastasis
- • progressive neuromuscular and neurological diseases
- • unstable cardiac disease
- • pulmonary hypertension
- • interstitial lung disease
- • orthopedic conditions that significantly impair functional status
- • mental or psychiatric disorders that impair the ability to comply with study procedures.
- • a history of cerebrovascular accident with remaining functional consequences
- • a history of lung cancer
- • difficulties in understanding and speaking Dutch
About Hasselt University
Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Genk, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials